Physician profile
Keith Thomas Applegate
NPI 1245235795
$5,291.52
in general payments reported to CMS, 2019-2025
40 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $73.76 · 2021: $493 · 2022: $686 · 2023: $958 · 2024: $1,332 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,422 · Education: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,421.60 |
| Education | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $721.73 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $525.00 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $506.01 | 2019-2025 | Airsupra, Farxiga |
| Abbvie INC. | $499.26 | 2019-2024 | Qulipta, Vraylar |
| Novo Nordisk INC | $437.98 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $425.09 | 2019-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $342.00 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $243.83 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Takeda Pharmaceuticals U.S.A., INC. | $161.73 | 2019-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.51 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.66 | 2021-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $90.37 | 2021-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Gilead Sciences, INC. | $86.85 | 2025 | |
| Phathom Pharmaceuticals, INC. | $85.33 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $79.74 | 2023-2024 | Cologuard Collection Kit |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Applegate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.